|
KMID : 0370220230670050285
|
|
Yakhak Hoeji
2023 Volume.67 No. 5 p.285 ~ p.293
|
|
|
Characteristics and User Evaluation of Digital Therapeutics: An Exploratory Study Focusing on reSET®, reSET-O®, and Somryst®
|
|
Jeong Yu-Rim
Park Eun-Young
Baek Dong-Jae
Bang Joon-Seok
Kim Kwang-Joon
|
|
|
Abstract
|
|
|
|
Digital therapeutics (DTx) are defined as high-quality software designed to prevent, manage, and treat medicaldisorders or diseases by providing evidence-based therapeutic interventions. In this study, an investigation was conducted to examine the characteristics of DTx, including their methods, safety-related data, and user evaluations of reSET®, reSET-O®, and Somryst®. These DTx solutions have recently obtained the first FDA approval and the first insurance code registration by government. However, there are limitations in terms of the quantitative scale of patient feedback evaluations and concerns about accuracy, as indicated by research findings. Nevertheless, with the active global development of DTx and the increasing scale of investment, pharmacists need to pay attention to and prepare for this innovative treatment concept.
|
|
|
KEYWORD
|
|
|
Characteristics of digital therapeutics, User evaluations, Pharmacist
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|